Global Transcranial Doppler Ultrasound Market - 2023-2030

Global Transcranial Doppler Ultrasound Market - 2023-2030

The Global Transcranial Doppler Ultrasound Market reachedUS$ 27.3 million in 2022 and is expected to reach US$ 43.0 million by 2030, growing with a CAGR of 6.7% during the forecast period 2023-2030. Transcranial doppler ultrasound test detects stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, and tiny blood clots. It is a painless test that uses sound waves to detect medical problems that affect blood flow in the brain.

Furthermore, the increase in the prevalence of the diseases can elevate the transcranial doppler ultrasound market size. Due to the increase in healthcare expanditure in the countries like the U.S. and Canada, the market is experiencing an increase in demand in North American region. Significant key players like Viasonix, Rimed, Dawei Medical, and others are actively operating in the market.

Market Dynamics

Increase in the Number of Sickle Cell Diseases can Elevate the Market Growth

An increase in the number of sickle cell disorders can elevate the market growth. For instance, sickle cell diseases (SCD) affects approximately 100,000 Americans. SCD occurs among about 1 out of every 365 black or African-American births. SCD occurs among about 1 out of every 16,300 hispanic-American births. About 1 in 13 black or African-American babies is born with sickle cell trait (SCT).

Additionally, transcranial doppler ultrasound is an essential test for children with certain type of sickle cell disease. Stroke is one of the most severe complications in children suffering from sickle cell disease (SCD), affecting approximately 5-10% of children with an incidence peak in the first decade of life. This test can help determine the child's risk for stroke. Thus, an increase in the number of sickle cell diseases can elevate market growth.

Rise in the Prevalence of Ischemic Strokes can Accelerate Market Growth

The increase in the prevalence of ischemic strokes can elevate market growth. For instance, every year, more than 790,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes—nearly 1 in 4—are in people with a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

It can detect stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, tiny blood clots, and more. Transcranial doppler (TCD) is one of the most useful tools in diagnosing acute ischemic stroke. It provides valuable information about microemboli, the degree of cerebral vessel stenosis, and collateral flow. Thus, an increase in the prevalence of ischemic strokes can raise market growth.

Limitations associated with the TCDs can HamperMarket Growth

The limitations associated with the TCDs are technical challenges to insonate the correct artery within the cranial vault. It may also be difficult to obtain doppler waveforms in elderly patients because of the attenuation of ultrasound energy through a thick skull typical in such patients (12–19% of patients with acute stroke). Because of more averaging of information at slower frame rates, slow-moving soft tissue signals appear as flash artifacts. Thus, the limitations associated with TCDs can hamper market growth.

Segment Analysis

The global transcranial doppler ultrasound market is segmented based on type, technology, application, end-user and region.

The Pulsed Wave Doppler Segment Accounted for Approximately 39.8% of the Transcranial Doppler Ultrasound Market Share.

The increase in the advancements of the products can expand the growth of the segment. For instance, on February 9, 2022, Royal Philips announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on the company’s Lumify handheld point-of-care ultrasound device. The pulsed wave doppler (PW Doppler) sends short pulses of ultrasound and analyzes reflected sound waves between the pulses.

By sending short and quick pulses of sound, it accurately measures the velocity of blood in a precise location and in real time. The crystals alternate rapidly between sending and analyzing ultrasound. Thus, an increase in the advancements in the products is driving the growth of the segment.

Geographical Penetration

North America Accounted for Approximately 47.2% of the Market Share in 2022.

North America is expected to hold a significant position in the transcranial doppler ultrasound market share. Due to the increase in technological advancements, innovations, and launches, there is a growth of the market in this region. For instance, on March 4, 2021, EchoNous, the leading developer of AI-driven, hand-carried ultrasound, announced the addition of both continuous wave (CW) and pulsed wave (PW) doppler capabilities to the Kosmos hardware platform, the company's flagship offering.

This innovation represents an industry first for an ultra-mobile ultrasound product, creating the first ""hybrid"" point-of-care ultrasound (POCUS) device, offering extensive machine-benchmarked ultrasound imaging and doppler functionality in a hand-carried unit (HCU). Thus, an increase in technological advancements in the products and the launches is driving the growth of the market.

Competitive Landscape

The major global players in the transcranial doppler ultrasound market include Viasonix, Rimed, Dawei Medical, Konica Minolta Healthcare India Pvt. Ltd., NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB, Shenzhen Delica Medical Equipment Co., Ltd. and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant influence on the transcranial doppler ultrasound market, posing unprecedented challenges to many countries. The delayed launches and innovations have shown a negative impact on the usage of transcranial doppler ultrasound. The reduced number of product approvals has reduced market growth. Thus, COVID-19 has declined the growth of the transcranial doppler ultrasound market.

By Type
• Non-Duplex TCDs
• Duplex TCDs

By Technology
• Continuous wave Doppler
• Pulsed Wave Doppler

By Application
• Sickle Cell Disease
• Acute Ischemic Stroke
• Intracranial Steno Occlusive Disease
• Vasospasm
• Others

By End-User
• Hospitals
• Diagnostic Laboratories
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• On February 28, 2023, NovaSignal announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA, in order to advance stroke research and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications in the region.
• On July 13, 2022, Delica is pleased to announce that they have begun serving the US market with the approval of the Transcranial Doppler EMS-9M by the US FDA. Most recent wireless TCD in the world is called EMS-9M. It is a battery-powered, battery-powered system. Both in sedentary and active modes, it can be used for cerebral evaluations as well as investigations of peripheral and microvascular regions.
• On March 15, 2022, a medical technology and data company specializing in the assessment and management of brain health announced that its NovaGuide Intelligent Ultrasound has been granted a Medical Device Licence by Health Canada. NovaGuide is now available to Canadian healthcare practitioners for use in capturing and monitoring blood flow in the brain in real-time.

Why Purchase the Report?
• To visualize the global transcranial doppler ultrasound market segmentation based on type, technology, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of transcranial doppler ultrasound market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key products of all the major players.

The global transcranial doppler ultrasound market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies